In addition, lower EGFR amplification rates in patients with GBM from Asia were recently reported during a screening for the INTELLANCE1 and INTELLANCE2 randomized GBM trials compared to that in other regions,29 which may be due to racial differences. Here, EGFR is linked to glioblastoma.